HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Where Veptigastrant fits in practice
Survey results and Hamilton's view on using PROTACs earlier versus after other endocrine agents are explored.
Play episode from 33:55
Transcript
